查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1844167

心臟假體設備市場按產品類型、手術方法、材料類型、最終用戶和適應症分類－2025-2032 年全球預測

Cardiac Prosthetic Devices Market by Product Type, Procedure Approach, Material Type, End User, Indication - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年心臟假體設備市場規模將成長至 332.4 億美元，複合年成長率為 16.22%。

主要市場統計數據
基準年2024年 99.8億美元
預計2025年 115.7億美元
預測年份：2032年 332.4億美元
複合年成長率（%） 16.22%

權威介紹設備設計創新、臨床實踐轉變和不斷變化的監管期望如何重新定義心臟假體設備策略

心臟假體裝置領域正處於先進生物醫學工程、不斷發展的臨床實踐和日新月異的醫療經濟的動態交匯點。過去十年，醫療專業人員和設備製造商已不再局限於逐步的改進，而是追求集機械可靠性、生物相容性材料和手術多功能性於一體的整合解決方案。這一發展反映了臨床醫生對能夠降低手術全期風險、縮短康復時間並改善日益複雜的患者群體長期功能預後的設備日益成長的需求。

同時，監管審查的加強和付款人期望的提高，迫使製造商提供強力的真實世界證據，並向醫院和心臟中心展示清晰的價值提案。供應鏈的複雜性和零件的專業化程度不斷提高，帶來了新的採購和製造考量，迫使目標商標產品製造商重新思考供應商關係和垂直能力。因此，經營團隊之間的策略討論已變得司空見慣，不僅涵蓋產品設計，還涵蓋證據生成、服務模式和生命週期經濟效益。

展望未來，差異化機會可能集中在融合創新上，例如微型電子設備、先進的聚合物和組織解決方案、更佳的設備耐用性以及可實現微創介入的手術方法。相關人員若能將臨床證據計畫、監管途徑和商業化策略協調一致，將最有可能將科學前景轉化為持續的臨床應用和長期的商業性成功。

前瞻性地綜合了正在重塑心臟假體設備生態系統的根本程序創新、材料進步和商業性調整

心臟假體領域正在經歷一系列變革，重塑競爭優勢和臨床實踐。在導管輸送系統和影像技術進步的推動下，經導管技術正在拓展先前僅透過開胸心臟手術即可解決的適應症，並使其能夠治療高風險患者。同時，設備小型化以及將感測和連接技術整合到植入式平台，正在實現遠端監控、自適應治療流程，並與基於價值的醫療模式更緊密地整合。

材料科學帶來了更持久的生物和合成材料，可降低血栓形成風險並改善動態。而積層製造和精密加工等製造創新則使更複雜的幾何形狀和客製化的設備尺寸成為可能。醫療保健系統越來越關注醫療總成本，推動強調手術效率、縮短住院時間和降低併發症發生率的設備策略。最後，資料共用計畫和風險共擔協議正在加速證據產生和報銷協調，設備公司、臨床中心和付款人之間的合作模式也日益普及。

這些轉變雖然在不同地區和臨床環境中存在差異，但卻提高了參與企業和現有企業的門檻。成功的關鍵在於將臨床、監管和商業等要素整合成一個連貫的項目，從而在實際臨床環境中證明其對患者的益處和經濟合理性。

深入分析不斷變化的美國貿易措施如何重塑整個心臟假體供應鏈的採購、製造足跡和臨床可及性

美國近期政策調整引發的貿易措施不斷演變，正在對心臟假體設備的採購、製造和臨床供應鏈產生一系列累積效應。直接影響是某些進口零件的到岸成本上升，促使設備製造商和經銷商重新評估供應商合約和庫存策略。為此，許多公司正在加速供應商多元化、雙重籌資策略和區域庫存緩衝，以保障手術室的正常營運，並降低單一來源中斷的風險。

除了短期價格壓力外，這些貿易動態也影響製造地和資本配置的策略決策。一些製造商正在評估近岸外包方案或增加對國內產能的投資，以降低關稅風險並縮短關鍵零件的前置作業時間。此類轉變不僅會影響成本結構和單位經濟效益，也為韌性帶來潛在益處，而韌性對於維持臨床供應的連續性至關重要。

在選擇供應商時，臨床醫生和醫院採購團隊越來越關注醫療總成本，而不僅僅是單價，他們會考慮設備的可靠性、服務覆蓋範圍和診療流程。監管機構和付款方正在密切關注這些變化，因為供應鏈重組可能會影響設備的可用性和醫療服務的連續性。最終，隨著貿易政策的演變，相關人員積極模擬資費驅動情景、與供應商合作控制成本並與醫療保健系統進行有效溝通的利益相關者，將更有能力保護淨利率和患者可及性。

全面的細分洞察揭示了產品類型、程序方法、材料選擇、最終用戶需求和臨床適應症如何相互交織，從而形成商業和臨床策略

細緻的細分揭示了臨床需求、手術偏好和材料科學如何融合，從而推動差異化商機。以產品類型來看，植入式心臟整流去顫器市場包含不同的子類別，例如雙腔、單腔和皮下系統，每種系統都有其獨特的臨床用例和技術要求。左心室輔助裝置分為耐用型和臨時型，反映了不同的患者群體和服務模式。心律調節器包括雙心室、雙腔和單腔設計，起搏方式和編程複雜性會影響後續護理和遠端監控的需求。人工瓣膜分為生物瓣膜和機械瓣膜，其中生物瓣膜分為同種異體移植瓣膜和異種移植瓣膜，機械瓣膜分為雙側瓣膜和傾斜瓣膜設計。

當需要解剖學考慮或進行複雜修復時，開胸手術仍然很重要，而微創手術和傳統胸骨切開術等手術變體正在影響醫院資源的利用率。經導管手術，包括主動脈瓣和二尖瓣置換術，正在擴大老年和高風險患者的治療範圍，從而推動導管設計和影像引導方面的投資。材料類型仍然是決定性因素，生物假體選項可提供良好的血流動力學和生物整合性，而機械選項則可提供長期耐用性。在這些類別中，同種異體移植與異質骨移植、雙瓣膜與傾斜盤等區別會影響臨床選擇和後續管理。

門診手術中心、心臟中心和醫院的終端使用者細分凸顯了不同的採購偏好和服務期望。門診患者優先考慮效率和吞吐量，而心臟中心和醫院則強調全面的護理路徑和複雜的病例處理量。根據主動脈瓣、二尖瓣、肺動脈瓣和三尖瓣病變的適應症水平以及主動脈瓣和二尖瓣逆流和狹窄的亞類進行區分，進一步細化了臨床需求概況，並決定了器械的外形規格、輸送系統和證據生成的優先級。了解這些相互交織的細分軸，製造商和醫療保健系統可以根據手術方法、材料選擇和終端用戶操作限制的具體需求，客製化產品開發、培訓和商業模​​式。

從策略上評估美洲、中東和非洲以及亞太地區的地理差異如何影響臨床應用、監管方法和商業策略

區域動態顯著影響著人工心臟的開發、核准、採用和支持方式。在美洲，成熟的報銷環境和高度集中的先進心臟中心催生了對創新經導管解決方案、整合遠端監控和長期設備服務項目的需求。該地區的臨床領導者通常透過比較研究和註冊參與來推動證據生成，而商業性成功通常取決於強大的臨床關係和捆綁式醫療提案。

歐洲、中東和非洲地區的監管和報銷格局各不相同，高所得西歐市場與其他注重成本控制的地區在採用模式上有顯著差異。在許多歐洲市場，集中採購框架和強大的國家註冊體系支持強而有力的上市後監管，而報銷體系和衛生技術評估則影響高階設備的採用率。歐洲、中東和非洲市場表現出來自三級心臟中心和入境醫療旅遊的選擇性需求，這為專業產品和服務組合創造了利基市場機會。

亞太地區臨床能力快速提升，患者數量龐大，國內生產能力不斷提升。該地區多個市場正在大力投資微創和經導管項目，並得到當地臨床培訓計劃和夥伴關係的支持。價格敏感性和多元化的支付方結構正在推動生產規模擴大和成本效益更高的設備設計，同時，主要市場的監管機構正在簡化途徑以促進創新。在整個地區，那些將臨床開發、監管策略和上市模式與當地機構獎勵和採購規範相結合的公司將找到最永續的採用途徑。

關於設備製造商如何利用研究、夥伴關係和服務模式來確保心臟假體市場的領導地位的主要考察

為了維持並擴大競爭地位，心臟假體領域的主要企業正在尋求創新、擴展服務和生態系統夥伴關係關係的結合。研發重點包括下一代瓣葉技術、更細的導管系統、改良的植入式心律管理設備的感測演算法，以及簡化植入並減少設備相關併發症的機械設計。在商業性，公司正在投資培訓中心、測試網路和長期服務協議，以增強臨床忠誠度並產生穩定的售後市場收益。

併購仍然是一個策略性槓桿，能夠更快地獲得互補技術、製造能力和地理覆蓋範圍。隨著設備製造商尋求提供整合的手術解決方案而非獨立的植入，與影像處理公司、數位醫療公司和臨床網路的策略聯盟變得越來越頻繁。同時，新參與企業和專業供應商正在加速對組件和輸送系統的競爭，迫使現有企業透過臨床證據和供應商支援模式來實現差異化。

在監管機構和醫院日益重視器械可追溯性和上市後性能的當下，卓越的製造和品質系統運作仍然是一項不容置疑的能力。那些將產品藍圖與持久的服務生態系統、清晰的報銷策略和高效的全球製造相結合的公司，最有可能將其研發投資轉化為永續的商業性回報。

為設備開發商和衛生系統領導者提供可操作的優先建議，以建立有彈性的供應鏈、證據計劃和與付款人一致的商業化策略

行業領導者應優先考慮多維度的方法，在創新、營運韌性和付款人參與之間取得平衡。首先，投資於臨床證據項目，這些項目應利用註冊資料庫、比較有效性試驗和真實世界數據，證明患者治療結果和醫療成本顯著改善，從而為臨床醫生和付款人建立令人信服的敘事。其次，考慮區域製造或雙重採購，以加強供應商關係，避免貿易政策波動，並保障醫院流程的連續性。

對於門診手術中心，我們將開發注重手術效率的精簡產品；而對於心臟中心和三級醫院，我們將設計全面的培訓和服務方案。第四，我們將把數位化能力融入我們的設備和患者管理路徑，以支持遠端隨訪，及早發現併發症，並為付款人帶來可量化的價值。第五，我們將進行有針對性的地理擴張，以加速在重點市場的採用，並將臨床培訓投資與監管和報銷導航相結合。

最後，採取積極主動的方式與監管機構和付款人溝通，預測政策變化並確保獲得有利的覆蓋途徑。透過將研發重點與報銷策略和供應鏈韌性相結合，實施這些建議的公司將能夠降低商業化風險並建立永續的競爭優勢。

清楚地解釋我們的混合調查方法，結合臨床醫生訪談、監管和臨床證據審查以及供應鏈分析，得出可靠、可行的見解

該研究結合了對心臟外科醫生、介入性心臟病專家、採購負責人和設備工程師的專家訪談，以及對監管申報、臨床試驗註冊和同行評審臨床文獻的系統性回顧，得出了初步結論。該研究對定量和定性輸入進行了三角測量，以確定不同產品類型和操作方法的採用促進因素、臨床障礙和營運限制。

為了評估脆弱性和緩解途徑，我們利用供應商圖譜、進出口趨勢評估和採購案例研究，建構了供應鏈和關稅分析。產品細分是透過將產品分類與臨床適應症、操作方法和最終用戶動態相結合而製定的，確保每個維度都以臨床醫生的實踐模式和醫院的運作實際情況為依據。品管包括訪談主題的交叉檢驗、技術專家的迭代審查（以確保方法學的透明度）以及結論和建議的穩健性。

這種混合方法提供了設備設計、臨床實踐、管理體制和商業系統如何相互作用的整體視圖，提供了可操作的、基於當前臨床和操作證據的見解。

總之，我們強調迫切需要協調臨床、監管和營運策略，以將創新轉化為持續的臨床應用和市場彈性。

總而言之，人工心臟領域正處於曲折點，臨床創新、程序轉型、材料進步和不斷發展的商業模式正在匯聚，重塑病患照護路徑。將產品開發與嚴謹的證據產生、靈活的生產策略和支付方參與同步進行，將獲得最大價值，並在各種臨床環境中持續推廣應用。

關稅和貿易動態增加了新的營運複雜性，凸顯了供應商策略、區域生產決策以及與醫療系統合作夥伴透明溝通的重要性。同時，在地化商業化和臨床整合服務模式提供了一條清晰的差異化路徑：將研發投資與已證實的臨床需求相結合，強化供應鏈以應對政策變化，並建立必要的實證和商業性基礎，將創新轉化為改善的患者治療效果和持續的市場表現。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 以經導管主動脈瓣置換術作為低風險患者族群的標準治療
  • 將人工智慧和機器學習融入設備開發和病患監測工作流程
  • 3D 列印個人化心臟瓣膜假體的進展，可改善解剖貼合度及治療效果
  • 經皮二尖瓣修復系統擴大了二尖瓣逆流患者的治療選擇
  • 開發具有更高耐用性和更低鈣化率的下一代生物心臟瓣膜
  • 心臟裝置植入後患者管理中遠端監控和追蹤技術的興起
  • 監管協調和加速核准流程將加速全球心臟假體創新
  • 基於生物工程組織的心臟瓣膜可最大限度地減少血栓形成並消除長期抗凝血治療的需要
  • 經導管結構性心臟介入治療的擴展將推動新興市場的成長
  • 成本效益和基於價值的定價壓力不斷增加將影響心臟假體設備的採購

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

8. 心臟假體設備市場（依產品類型）

  • 植入式心臟整流去顫器
    • 雙腔去心房顫動
    • 單腔去心房顫動
    • 皮下去心房顫動
  • 左心室補助人工心臟
    • 耐用的心室輔助裝置
    • 暫時性心室輔助裝置
  • 心律調節器
    • 雙心室節律器
    • 雙腔心律調節器
    • 單腔心律調節器
  • 人工瓣膜
    • 生物瓣膜
    • 機械閥

9. 心臟假體設備市場（依手術方式）

  • 心臟直視手術
    • 微創手術
    • 傳統胸骨切開術
  • 經導管
    • 經導管主動脈瓣置換術
    • 經導管二尖瓣置換術

第 10 章：心臟假體裝置市場（依材料類型）

  • 生物假體
    • 同種異體移植
    • 異種移植
  • 機器
    • 雙葉
    • 斜盤

第 11 章。心臟假體設備市場（依最終用戶）

  • 門診手術中心
  • 心臟中心
  • 醫院

第 12 章：心臟假體設備市場（按適應症）

  • 主動脈
    • 回流
    • 收縮
  • 二尖瓣
    • 回流
    • 收縮
  • 肺
  • 三尖瓣

第 13 章：心臟假體設備市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第 14 章心臟假體設備市場（按類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 15 章。心臟假體設備市場（依國家）

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Medtronic plc
    • Edwards Lifesciences Corporation
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Johnson & Johnson
    • LivaNova PLC
    • Terumo Corporation
    • Biotronik SE & Co. KG
    • MicroPort Scientific Corporation
    • CryoLife, Inc.
Product Code: MRR-ED54C46E8699

The Cardiac Prosthetic Devices Market is projected to grow by USD 33.24 billion at a CAGR of 16.22% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 9.98 billion
Estimated Year [2025] USD 11.57 billion
Forecast Year [2032] USD 33.24 billion
CAGR (%) 16.22%

An authoritative introduction to how innovation in device design, clinical practice shifts, and evolving regulatory expectations are redefining cardiac prosthetic device strategy

The field of cardiac prosthetic devices sits at a dynamic intersection of advanced biomedical engineering, evolving clinical practice, and shifting healthcare economics. Over the last decade practitioners and device makers have moved beyond incremental improvements to pursue integrated solutions that combine mechanical reliability, biocompatible materials, and procedural versatility. This evolution reflects growing clinician demand for devices that reduce perioperative risk, shorten recovery time, and improve long-term functional outcomes for increasingly complex patient cohorts.

Regulatory scrutiny and payer expectations have concurrently heightened, requiring manufacturers to generate robust real-world evidence and demonstrate clear value propositions to hospitals and cardiac centers. Supply chain complexity and component specialization have introduced new procurement and manufacturing considerations, prompting original equipment manufacturers to rethink supplier relationships and vertical capabilities. As a result, strategy discussions among executive teams now routinely consider not only product design but also evidence generation, service models, and lifecycle economics.

Looking ahead, opportunities for differentiation will center on convergent innovations: miniaturized electronics, advanced polymer and tissue solutions, device durability enhancements, and procedural approaches that favor less invasive access. Stakeholders who align clinical evidence plans, regulatory pathways, and commercialization tactics will be best positioned to translate scientific promise into sustained clinical adoption and long-term commercial success.

A forward looking synthesis of radical procedural innovations, materials advances, and commercial realignments that are reshaping the cardiac prosthetic device ecosystem

The cardiac prosthetic landscape is undergoing a set of transformative shifts that are remapping competitive advantage and clinical practice. Transcatheter techniques, propelled by advances in catheter delivery systems and imaging, are expanding indications previously handled via open cardiac surgery and enabling treatment of higher-risk patients. At the same time, device miniaturization and the integration of sensing and connectivity into implantable platforms are enabling remote monitoring, adaptive therapy algorithms, and closer alignment with value-based care models.

Materials science has introduced longer-lasting biological and synthetic options that reduce thrombogenicity and improve hemodynamic performance, while manufacturing innovations such as additive manufacturing and precision machining are enabling more complex geometries and tailored device footprints. Health systems are placing greater emphasis on total cost of care, driving device strategies that emphasize procedural efficiency, reduced length of stay, and lower complication rates. Finally, collaborative models between device companies, clinical centers, and payers are becoming more common, with shared data initiatives and risk-sharing agreements accelerating evidence generation and reimbursement alignment.

These shifts are not uniform across geographies or clinical settings, but together they are raising the bar for entrants and incumbents alike: success will depend on integrating clinical, regulatory, and commercial threads into coherent programs that can demonstrate patient benefit and economic rationale in real-world practice.

An in depth analysis of how evolving United States trade measures are cumulatively reshaping procurement, manufacturing footprints, and clinical access across cardiac prosthetic supply chains

Evolving trade measures originating from recent policy adjustments in the United States have introduced a set of cumulative effects across procurement, manufacturing, and clinical supply chains for cardiac prosthetic devices. The immediate impact has been higher landed costs for certain imported components, prompting device manufacturers and distributors to reassess supplier contracts and inventory strategies. In response, many organizations have accelerated supplier diversification, dual-sourcing strategies, and regional inventory buffers to protect operating room schedules and reduce exposure to single-source disruptions.

Beyond short-term pricing pressure, these trade dynamics are influencing strategic decisions around manufacturing footprint and capital allocation. Some manufacturers are evaluating near-shoring options or investing in additional domestic capabilities to mitigate tariff risk and shorten lead times for critical components. These shifts carry implications for cost structures and unit economics, but they also offer potential resilience benefits that can be essential in maintaining clinical supply continuity.

Clinicians and hospital procurement teams are increasingly focused on total cost of care rather than unit price alone, factoring in device reliability, service coverage, and procedure throughput when selecting suppliers. Regulatory bodies and payers are watching these changes closely, as supply chain reconfiguration can affect device availability and continuity of care. Ultimately, stakeholders that proactively model tariff-driven scenarios, engage suppliers in collaborative cost-management, and communicate effectively with health systems will be better equipped to safeguard both margins and patient access as trade policy evolves.

Comprehensive segmentation insight revealing how product type, procedure approach, material selection, end user needs, and clinical indication intersect to shape commercial and clinical strategies

A nuanced segmentation view reveals where clinical demand, procedural choice, and material science converge to drive differentiated opportunities. When examining the market by product type, implantable cardioverter defibrillators present distinct subcategories including dual chamber, single chamber, and subcutaneous systems, each with unique clinical use cases and technology requirements. Left ventricular assist devices divide into durable and temporary solutions, reflecting divergent patient populations and service models. Pacemakers include biventricular, dual chamber, and single chamber devices, where pacing modality and programming complexity influence follow-up care and remote monitoring needs. Valve prostheses are split between bioprosthetic and mechanical options, with bioprosthetic valves further characterized by homograft and xenograft derivations, and mechanical valves differentiated by bileaflet and tilting disc designs, all of which carry implications for durability, anticoagulation management, and patient counseling.

Approach to procedure further stratifies adoption pathways: open heart surgery remains relevant where anatomical considerations or complex repair are necessary, with subvariants such as minimally invasive surgery and traditional sternotomy shaping hospital resource utilization. The transcatheter route, encompassing aortic and mitral valve replacement approaches, has expanded access to interventions for older or higher-risk patients and is driving investment in catheter design and imaging support. Material type continues to be a defining axis, with bioprosthetic options offering favorable hemodynamics and biological integration and mechanical choices providing long term durability; within these classes, distinctions such as homograft versus xenograft or bileaflet versus tilting disc inform both clinical selection and downstream management.

End user segmentation across ambulatory surgical centers, cardiac centers, and hospitals highlights diverse procurement preferences and service expectations, with ambulatory settings prioritizing efficiency and throughput while cardiac centers and hospitals emphasize comprehensive care pathways and complex case capabilities. Indication-level differentiation across aortic, mitral, pulmonary, and tricuspid lesions, and subcategories of regurgitation and stenosis for aortic and mitral pathologies, further refines clinical demand profiles, informing device form factors, delivery systems, and evidence generation priorities. Understanding these intersecting segmentation axes allows manufacturers and health systems to tailor product development, training, and commercial models to the specific needs of procedural approaches, material choices, and end user operational constraints.

A strategic assessment of how geographic differences across the Americas, Europe Middle East and Africa, and Asia Pacific shape clinical adoption, regulatory approach, and commercial strategy

Regional dynamics materially influence how cardiac prosthetic devices are developed, approved, adopted, and supported. In the Americas, a mature reimbursement environment and a high concentration of advanced cardiac centers create demand for innovative transcatheter solutions, integrated remote monitoring, and long-term device service programs. Clinical leaders in this region often drive evidence generation through comparative studies and registry participation, and commercial success typically hinges on strong clinical relationships and bundled care propositions.

The Europe, Middle East & Africa region presents a heterogeneous regulatory and reimbursement landscape where adoption patterns vary significantly between high-income Western European markets and other jurisdictions that may prioritize cost containment. In many European markets, centralized procurement frameworks and strong national registries support robust post-market surveillance, while reimbursement mechanisms and health technology assessment influence the speed of uptake for premium devices. Middle Eastern and African markets show selective demand driven by tertiary cardiac centers and inbound medical travel, creating niche opportunities for specialized products and service bundles.

Asia-Pacific combines rapidly expanding clinical capacity with large patient volumes and growing domestic manufacturing capabilities. Several markets in the region are investing heavily in minimally invasive and transcatheter programs, supported by local clinical training initiatives and partnerships. Pricing sensitivity and diverse payer structures encourage scaled manufacturing and cost-effective device designs, while regulatory authorities in leading markets are streamlining pathways to encourage innovation. Across regions, companies that align clinical development, regulatory strategy, and go-to-market models to local system incentives and procurement norms will find the most durable routes to adoption.

Key competitive and operational insights into how device manufacturers are leveraging research, partnerships, and service models to secure leadership in cardiac prosthetic markets

Leading companies in the cardiac prosthetic arena are pursuing a mix of innovation, service expansion, and ecosystem partnerships to protect and extend competitive positions. R&D focus areas include next-generation valve leaflet technology, low-profile catheter systems, improved sensing algorithms for implantable rhythm management devices, and mechanical designs that simplify implantation or reduce device-related complications. Commercially, companies are investing in training centers, proctoring networks, and long-term service contracts that reinforce clinical loyalty and generate steady aftermarket revenue.

Mergers and acquisitions continue to be a strategic lever, enabling rapid access to complementary technologies, manufacturing capacity, and regional footprints. Strategic alliances with imaging companies, digital health firms, and clinical networks are becoming more frequent as device makers seek to deliver integrated procedural solutions rather than stand-alone implants. At the same time, new entrants and specialized suppliers are accelerating competition in components and delivery systems, compelling incumbents to sharpen differentiation through clinical evidence and provider support models.

Operational excellence in manufacturing and quality systems remains a non-negotiable competency, particularly as regulators and hospitals emphasize device traceability and post-market performance. Firms that align product roadmaps with durable service ecosystems, clear reimbursement strategies, and efficient global manufacturing will be best placed to convert R&D investment into sustained commercial returns.

Actionable and prioritized recommendations for device developers and health system leaders to build resilient supply chains, evidence programs, and payer aligned commercialization strategies

Industry leaders should prioritize a multidimensional approach that balances innovation with operational resilience and payer engagement. First, invest in clinical evidence programs that demonstrate meaningful improvements in patient outcomes and cost of care, using registries, comparative effectiveness studies, and real-world data to build compelling narratives for clinicians and payers. Second, strengthen supplier relationships and consider regional manufacturing or dual sourcing to hedge against trade policy volatility and protect procedural continuity in hospitals.

Third, align commercial models with how end users purchase and deploy devices: develop streamlined offerings for ambulatory surgical centers that emphasize procedural efficiency, while designing comprehensive training and service packages for cardiac centers and tertiary hospitals. Fourth, integrate digital capabilities into devices and patient management pathways to support remote follow-up, detect complications early, and provide quantifiable value to payers. Fifth, pursue targeted geographic expansion that pairs clinical training investments with regulatory and reimbursement navigation to accelerate uptake in priority markets.

Finally, adopt a proactive regulatory and payer engagement posture that anticipates policy changes and secures favorable coverage pathways. Companies that operationalize these recommendations-by connecting R&D priorities to reimbursement strategies and supply chain resilience-will reduce commercialization risk and build sustainable competitive advantage.

A clear explanation of the blended research approach combining clinician interviews, regulatory and clinical evidence review, and supply chain analysis to ensure robust actionable insights

This research synthesizes primary insights from expert interviews with cardiac surgeons, interventional cardiologists, procurement leaders, and device engineers, combined with a systematic review of regulatory filings, clinical trial registries, and peer reviewed clinical literature. Quantitative and qualitative inputs were triangulated to identify adoption drivers, clinical barriers, and operational constraints across product types and procedural approaches.

Supply chain and tariff analyses were constructed using supplier mapping, import-export trend reviews, and procurement case studies to assess vulnerability and mitigation pathways. Segmentation was developed by aligning product taxonomies with clinical indications, procedural approaches, and end user dynamics, ensuring that each axis was informed by clinician practice patterns and hospital operational realities. Quality control included cross-validation of interview themes, methodological transparency, and iterative review with technical experts to ensure the robustness of conclusions and recommendations.

This blended methodology enables a holistic view of how device design, clinical practice, regulatory regimes, and commercial systems interact, producing insights that are both actionable and grounded in current clinical and operational evidence.

A concluding synthesis emphasizing the urgency for coordinated clinical, regulatory, and operational strategies to convert innovation into sustained clinical adoption and market resilience

In conclusion, the cardiac prosthetic device landscape is at an inflection point where clinical innovation, procedural migration, material advancements, and commercial model evolution are converging to reshape patient care pathways. Organizations that synchronize product development with rigorous evidence generation, resilient manufacturing strategies, and payer engagement will capture the greatest value and sustain adoption across diverse clinical settings.

Tariff and trade dynamics add a new layer of operational complexity that amplifies the importance of supplier strategy, regional manufacturing decisions, and transparent communication with health system partners. At the same time, regionally tailored commercialization and clinically integrated service models offer clear routes to differentiation. The imperative for leaders is to act decisively: align R&D investment to proven clinical needs, fortify supply chains against policy shifts, and build the evidentiary and commercial scaffolding required to translate innovation into improved patient outcomes and durable market performance.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of transcatheter aortic valve replacement in low-risk patient populations as standard of care
  • 5.2. Integration of artificial intelligence and machine learning into device development and patient monitoring workflows
  • 5.3. Advancements in 3D printed personalized cardiac prosthetic valves for improved anatomical fit and outcomes
  • 5.4. Emergence of percutaneous mitral valve repair systems expanding treatment options for mitral regurgitation patients
  • 5.5. Development of next-generation bioprosthetic heart valves with enhanced durability and reduced calcification rates
  • 5.6. Rise of telemonitoring and remote follow-up technologies for post-implant cardiac device patient management
  • 5.7. Regulatory harmonization and fast-track approval pathways accelerating cardiac prosthetic device innovations globally
  • 5.8. Bioengineering of tissue-based heart valves to minimize thrombogenicity and eliminate long-term anticoagulation requirements
  • 5.9. Expansion of transcatheter structural heart interventions driving market growth in emerging economies
  • 5.10. Increasing cost-effectiveness and value-based pricing pressures shaping procurement of cardiac prosthetic devices

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cardiac Prosthetic Devices Market, by Product Type

  • 8.1. Implantable Cardioverter Defibrillators
    • 8.1.1. Dual Chamber Defibrillators
    • 8.1.2. Single Chamber Defibrillators
    • 8.1.3. Subcutaneous Defibrillators
  • 8.2. Left Ventricular Assist Devices
    • 8.2.1. Durable Ventricular Assist Devices
    • 8.2.2. Temporary Ventricular Assist Devices
  • 8.3. Pacemakers
    • 8.3.1. Biventricular Pacemakers
    • 8.3.2. Dual Chamber Pacemakers
    • 8.3.3. Single Chamber Pacemakers
  • 8.4. Valve Prostheses
    • 8.4.1. Bioprosthetic Valves
    • 8.4.2. Mechanical Valves

9. Cardiac Prosthetic Devices Market, by Procedure Approach

  • 9.1. Open Heart Surgery
    • 9.1.1. Minimally Invasive Surgery
    • 9.1.2. Traditional Sternotomy
  • 9.2. Transcatheter
    • 9.2.1. Transcatheter Aortic Valve Replacement
    • 9.2.2. Transcatheter Mitral Valve Replacement

10. Cardiac Prosthetic Devices Market, by Material Type

  • 10.1. Bioprosthetic
    • 10.1.1. Homograft
    • 10.1.2. Xenograft
  • 10.2. Mechanical
    • 10.2.1. Bileaflet
    • 10.2.2. Tilting Disc

11. Cardiac Prosthetic Devices Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Cardiac Centers
  • 11.3. Hospitals

12. Cardiac Prosthetic Devices Market, by Indication

  • 12.1. Aortic
    • 12.1.1. Regurgitation
    • 12.1.2. Stenosis
  • 12.2. Mitral
    • 12.2.1. Regurgitation
    • 12.2.2. Stenosis
  • 12.3. Pulmonary
  • 12.4. Tricuspid

13. Cardiac Prosthetic Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Cardiac Prosthetic Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Cardiac Prosthetic Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Medtronic plc
    • 16.3.2. Edwards Lifesciences Corporation
    • 16.3.3. Abbott Laboratories
    • 16.3.4. Boston Scientific Corporation
    • 16.3.5. Johnson & Johnson
    • 16.3.6. LivaNova PLC
    • 16.3.7. Terumo Corporation
    • 16.3.8. Biotronik SE & Co. KG
    • 16.3.9. MicroPort Scientific Corporation
    • 16.3.10. CryoLife, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE APPROACH, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE APPROACH, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. CARDIAC PROSTHETIC DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. CARDIAC PROSTHETIC DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CARDIAC PROSTHETIC DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DUAL CHAMBER DEFIBRILLATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DUAL CHAMBER DEFIBRILLATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DUAL CHAMBER DEFIBRILLATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DUAL CHAMBER DEFIBRILLATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DUAL CHAMBER DEFIBRILLATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DUAL CHAMBER DEFIBRILLATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SINGLE CHAMBER DEFIBRILLATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SINGLE CHAMBER DEFIBRILLATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SINGLE CHAMBER DEFIBRILLATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SINGLE CHAMBER DEFIBRILLATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SINGLE CHAMBER DEFIBRILLATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SINGLE CHAMBER DEFIBRILLATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SUBCUTANEOUS DEFIBRILLATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SUBCUTANEOUS DEFIBRILLATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SUBCUTANEOUS DEFIBRILLATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SUBCUTANEOUS DEFIBRILLATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SUBCUTANEOUS DEFIBRILLATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SUBCUTANEOUS DEFIBRILLATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DURABLE VENTRICULAR ASSIST DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DURABLE VENTRICULAR ASSIST DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DURABLE VENTRICULAR ASSIST DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DURABLE VENTRICULAR ASSIST DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DURABLE VENTRICULAR ASSIST DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DURABLE VENTRICULAR ASSIST DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TEMPORARY VENTRICULAR ASSIST DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TEMPORARY VENTRICULAR ASSIST DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TEMPORARY VENTRICULAR ASSIST DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TEMPORARY VENTRICULAR ASSIST DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TEMPORARY VENTRICULAR ASSIST DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TEMPORARY VENTRICULAR ASSIST DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIVENTRICULAR PACEMAKERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIVENTRICULAR PACEMAKERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIVENTRICULAR PACEMAKERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIVENTRICULAR PACEMAKERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIVENTRICULAR PACEMAKERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIVENTRICULAR PACEMAKERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DUAL CHAMBER PACEMAKERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DUAL CHAMBER PACEMAKERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DUAL CHAMBER PACEMAKERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DUAL CHAMBER PACEMAKERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DUAL CHAMBER PACEMAKERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DUAL CHAMBER PACEMAKERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SINGLE CHAMBER PACEMAKERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SINGLE CHAMBER PACEMAKERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SINGLE CHAMBER PACEMAKERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SINGLE CHAMBER PACEMAKERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SINGLE CHAMBER PACEMAKERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SINGLE CHAMBER PACEMAKERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL VALVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL VALVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL VALVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL VALVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL VALVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL VALVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE APPROACH, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE APPROACH, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRADITIONAL STERNOTOMY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRADITIONAL STERNOTOMY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRADITIONAL STERNOTOMY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRADITIONAL STERNOTOMY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRADITIONAL STERNOTOMY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRADITIONAL STERNOTOMY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER AORTIC VALVE REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER AORTIC VALVE REPLACEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER AORTIC VALVE REPLACEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER AORTIC VALVE REPLACEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER AORTIC VALVE REPLACEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER AORTIC VALVE REPLACEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER MITRAL VALVE REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER MITRAL VALVE REPLACEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER MITRAL VALVE REPLACEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER MITRAL VALVE REPLACEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER MITRAL VALVE REPLACEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER MITRAL VALVE REPLACEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY HOMOGRAFT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY HOMOGRAFT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY HOMOGRAFT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY HOMOGRAFT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY HOMOGRAFT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY HOMOGRAFT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY XENOGRAFT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY XENOGRAFT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY XENOGRAFT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY XENOGRAFT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY XENOGRAFT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY XENOGRAFT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BILEAFLET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BILEAFLET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BILEAFLET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BILEAFLET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BILEAFLET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BILEAFLET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TILTING DISC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TILTING DISC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TILTING DISC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TILTING DISC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TILTING DISC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TILTING DISC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY CARDIAC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY CARDIAC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY CARDIAC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY CARDIAC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGURGITATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGURGITATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGURGITATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGURGITATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGURGITATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGURGITATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY STENOSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY STENOSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY STENOSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY STENOSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY STENOSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY STENOSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGURGITATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGURGITATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGURGITATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGURGITATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGURGITATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGURGITATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY STENOSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY STENOSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY STENOSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY STENOSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY STENOSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY STENOSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PULMONARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PULMONARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PULMONARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PULMONARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PULMONARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PULMONARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRICUSPID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRICUSPID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRICUSPID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRICUSPID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRICUSPID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRICUSPID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 259. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 260. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 261. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 263. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2024 (USD MILLION)
  • TABLE 264. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2025-2032 (USD MILLION)
  • TABLE 265. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, 2018-2024 (USD MILLION)
  • TABLE 266. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, 2025-2032 (USD MILLION)
  • TABLE 267. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2024 (USD MILLION)
  • TABLE 268. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, 2025-2032 (USD MILLION)
  • TABLE 269. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, 2018-2024 (USD MILLION)
  • TABLE 270. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, 2025-2032 (USD MILLION)
  • TABLE 271. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE APPROACH, 2018-2024 (USD MILLION)
  • TABLE 272. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE APPROACH, 2025-2032 (USD MILLION)
  • TABLE 273. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, 2018-2024 (USD MILLION)
  • TABLE 274. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, 2025-2032 (USD MILLION)
  • TABLE 275. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, 2018-2024 (USD MILLION)
  • TABLE 276. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, 2025-2032 (USD MILLION)
  • TABLE 277. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 278. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 279. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, 2018-2024 (USD MILLION)
  • TABLE 280. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, 2025-2032 (USD MILLION)
  • TABLE 281. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
  • TABLE 282. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, 2025-2032 (USD MILLION)
  • TABLE 283. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 284. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 285. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 286. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 287. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, 2018-2024 (USD MILLION)
  • TABLE 288. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, 2025-2032 (USD MILLION)
  • TABLE 289. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, 2018-2024 (USD MILLION)
  • TABLE 290. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, 2025-2032 (USD MILLION)
  • TABLE 291. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2018-202